In 2008, Gambineri et al. (37) reported the clinical and molecular profile of 14 unrelated affected males with IPEX caused by different mutations on FOXP3, pointing out to the lack of correlation between FOXP3 expression and disease severity. Here, FOXP3 is linked to immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.